{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:06:54Z","timestamp":1790417214571,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T00:00:00Z","timestamp":1563580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T00:00:00Z","timestamp":1563580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00277-019-03759-y","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T09:02:33Z","timestamp":1563613353000},"page":"2213-2220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation"],"prefix":"10.1007","volume":"98","author":[{"given":"Satoshi","family":"Yamasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Suzumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,20]]},"reference":[{"key":"3759_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon"},{"key":"3759_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0165-4608(97)00410-X","volume":"103","author":"SH Maljaei","year":"1998","unstructured":"Maljaei SH, Brito-Babapulle V, Hiorns LR, Catovsky D (1998) Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet Cytogenet 103:110\u2013116","journal-title":"Cancer Genet Cytogenet"},{"key":"3759_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ajh.24679","volume":"92","author":"Z Hu","year":"2017","unstructured":"Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X (2017) Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. Am J Hematol 92:441\u2013447","journal-title":"Am J Hematol"},{"key":"3759_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.hoc.2016.11.010","volume":"31","author":"A Sud","year":"2017","unstructured":"Sud A, Dearden C (2017) T-cell Prolymphocytic Leukemia. Hematol Oncol Clin North Am 31:273\u2013283","journal-title":"Hematol Oncol Clin North Am"},{"key":"3759_CR5","doi-asserted-by":"crossref","unstructured":"Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, It\u00e4l\u00e4-Remes M, Fo\u00e1 R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Rem\u00e9nyi P, Nagler A, Finke J, Turlure P, Iacobelli S, van Biezen A, Schetelig J, Kr\u00f6ger N, Dreger P (2019) EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL). Bone Marrow Transplant in press","DOI":"10.1038\/s41409-019-0448-x"},{"key":"3759_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF03006932","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, Kato K, Tabuchi K, Tsuchida M, Morishima Y, Mitamura M, Kawa K, Kato S, Nagamura T, Takanashi M, Kodera Y (2007) Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system. Int J Hematol 86:269\u2013274","journal-title":"Int J Hematol"},{"key":"3759_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y (2016) Introduction of transplant registry unified management program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol 103:3\u201310","journal-title":"Int J Hematol"},{"key":"3759_CR8","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/cncr.23375","volume":"112","author":"M Sorror","year":"2008","unstructured":"Sorror M, Storer B, Sandmaier BM, Maloney DG, Chauncey TR, Langston A, Maziarz RT, Pulsipher M, McSweeney PA, Storb R (2008) Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer 112:1992\u20132001","journal-title":"Cancer"},{"key":"3759_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reducedintensity conditioning regimen workshop: defining the dose spectrum-report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367\u2013369","journal-title":"Biol Blood Marrow Transplant"},{"key":"3759_CR10","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825\u2013828","journal-title":"Bone Marrow Transplant"},{"key":"3759_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945\u2013956","journal-title":"Biol Blood Marrow Transplant"},{"key":"3759_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"3759_CR13","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/annonc\/mdx163","volume":"28","author":"P Jain","year":"2017","unstructured":"Jain P, Aoki E, Keating M, Wierda WG, O'Brien S, Gonzalez GN, Ferrajoli A, Jain N, Thompson PA, Jabbour E, Kanagal-Shamanna R, Pierce S, Alousi A, Hosing C, Khouri I, Estrov Z, Cortes J, Kantarjian H, Ravandi F, Kadia TM (2017) Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). Ann Oncol 28:1554\u20131559","journal-title":"Ann Oncol"},{"key":"3759_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbmt.2009.11.021","volume":"16","author":"ME Kalaycio","year":"2010","unstructured":"Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M (2010) Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. Biol Blood Marrow Transplant 16:543\u2013547","journal-title":"Biol Blood Marrow Transplant"},{"key":"3759_CR15","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/leu.2011.304","volume":"26","author":"W Wiktor-Jedrzejczak","year":"2012","unstructured":"Wiktor-Jedrzejczak W, Dearden C, de Wreede L, van Biezen A, Brinch L, Leblond V, Brune M, Volin L, Kazmi M, Nagler A, Schetelig J, de Witte T, Dreger P, EBMT Chronic Leukemia Working Party (2012) Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium. Leukemia 26:972\u2013976","journal-title":"Leukemia"},{"key":"3759_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/ejh.12430","volume":"94","author":"T Guillaume","year":"2015","unstructured":"Guillaume T, Beguin Y, Tabrizi R, Nguyen S, Blaise D, Deconinck E, Redjoul R, Cornillon J, Guillerm G, Contentin N, Sirvent A, Turlure P, Salmon A, Huynh A, Fran\u00e7ois S, Peffault de Latour R, Yakoub-Agha I, Mohty M (2015) Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). Eur J Haematol 94:265\u2013269","journal-title":"Eur J Haematol"},{"key":"3759_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2018.01.009","volume":"67","author":"BR Dholaria","year":"2018","unstructured":"Dholaria BR, Ayala E, Sokol L, Nishihori T, Chavez JC, Hussaini M, Kumar A, Kharfan-Dabaja MA (2018) Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: a single-center experience. Leuk Res 67:1\u20135","journal-title":"Leuk Res"},{"key":"3759_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.celrep.2015.12.099","volume":"14","author":"JM Ali","year":"2016","unstructured":"Ali JM, Negus MC, Conlon TM, Harper IG, Qureshi MS, Motallebzadeh R, Willis R, Saeb-Parsy K, Bolton EM, Bradley JA, Pettigrew GJ (2016) Diversity of the CD4 T cell Alloresponse: the short and the long of it. Cell Rep 14:1232\u20131245","journal-title":"Cell Rep"},{"key":"3759_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/bmt.2016.305","volume":"52","author":"L Sellner","year":"2017","unstructured":"Sellner L, Br\u00fcggemann M, Schlitt M, Knecht H, Herrmann D, Reigl T, Krejci A, Bystry V, Darzentas N, Rieger M, Dietrich S, Luft T, Ho AD, Kneba M, Dreger P (2017) GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses. Bone Marrow Transplant 52:544\u2013551","journal-title":"Bone Marrow Transplant"},{"key":"3759_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/bjh.13952","volume":"173","author":"C L\u00f3pez","year":"2016","unstructured":"L\u00f3pez C, Bergmann AK, Paul U, Murga Penas EM, Nagel I, Betts MJ, Johansson P, Ritgen M, Baumann T, Aymerich M, Jayne S, Russell RB, Campo E, Dyer MJ, D\u00fcrig J, Siebert R (2016) Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia. Br J Haematol 173:265\u2013273","journal-title":"Br J Haematol"},{"key":"3759_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/gcc.22141","volume":"53","author":"AK Bergmann","year":"2014","unstructured":"Bergmann AK, Schneppenheim S, Seifert M, Betts MJ, Haake A, Lopez C, Maria Murga Penas E, Vater I, Jayne S, Dyer MJ, Schrappe M, D\u00fchrsen U, Ammerpohl O, Russell RB, K\u00fcppers R, D\u00fcrig J, Siebert R (2014) Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 53:309\u2013316","journal-title":"Genes Chromosomes Cancer"},{"key":"3759_CR22","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1182\/blood-2017-05-785683","volume":"130","author":"B Boidol","year":"2017","unstructured":"Boidol B, Kornauth C, van der Kouwe E, Prutsch N, Kazianka L, G\u00fcltekin S, Hoermann G, Mayerhoefer ME, Hopfinger G, Hauswirth A, Panny M, Aretin MB, Hilgarth B, Sperr WR, Valent P, Simonitsch-Klupp I, Moriggl R, Merkel O, Kenner L, J\u00e4ger U, Kubicek S, Staber PB (2017) First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia. Blood 130:2499\u20132503","journal-title":"Blood"},{"key":"3759_CR23","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-17-3644","volume":"78","author":"L He","year":"2018","unstructured":"He L, Tang J, Andersson EI, Timonen S, Koschmieder S, Wennerberg K, Mustjoki S, Aittokallio T (2018) Patient-customized drug combination prediction and testing for T-cell prolymphocytic leukemia patients. Cancer Res 78:2407\u20132418","journal-title":"Cancer Res"},{"key":"3759_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/leu.2017.252","volume":"32","author":"EI Andersson","year":"2018","unstructured":"Andersson EI, P\u00fctzer S, Yadav B, Dufva O, Khan S, He L, Sellner L, Schrader A, Crispatzu G, Ole\u015b M, Zhang H, Adnan-Awad S, Lagstr\u00f6m S, Bellanger D, Mpindi JP, Eldfors S, Pemovska T, Pietarinen P, Lauhio A, Tomska K, Cuesta-Mateos C, Faber E, Koschmieder S, Br\u00fcmmendorf TH, Kyt\u00f6l\u00e4 S, Savolainen ER, Siitonen T, Ellonen P, Kallioniemi O, Wennerberg K, Ding W, Stern MH, Huber W, Anders S, Tang J, Aittokallio T, Zenz T, Herling M, Mustjoki S (2018) Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. Leukemia 32:774\u2013787","journal-title":"Leukemia"},{"key":"3759_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41467-017-02688-6","volume":"9","author":"A Schrader","year":"2018","unstructured":"Schrader A, Crispatzu G, Oberbeck S, Mayer P, P\u00fctzer S, von Jan J, Vasyutina E, Warner K, Weit N, Pflug N, Braun T, Andersson EI, Yadav B, Riabinska A, Maurer B, Ventura Ferreira MS, Beier F, Altm\u00fcller J, Lanasa M, Herling CD, Haferlach T, Stilgenbauer S, Hopfinger G, Peifer M, Br\u00fcmmendorf TH, N\u00fcrnberg P, Elenitoba-Johnson KSJ, Zha S, Hallek M, Moriggl R, Reinhardt HC, Stern MH, Mustjoki S, Newrzela S, Frommolt P, Herling M (2018) Actionable perturbations of damage responses by TCL1\/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun 9:697","journal-title":"Nat Commun"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03759-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T23:26:54Z","timestamp":1595114814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03759-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,20]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3759"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03759-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,20]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the data management committee of the Japanese Society for Hematopoietic Cell Transplantation and the Institutional Review Board of Kyushu Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The Transplant Registry Unified Management Program database included physician-reviewed data. Observational studies based on the Transplant Registry Unified Management Program databases are performed with an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}